Nothing said here yet.
to join the conversation.
| Bauerlein AlisonChief Operating Officer | Sell | 25,260 | $223.6K | Fri, Oct 2 |
| Rodberg JamesChief Financial Officer | Sell | 7,208 | $63.8K | Fri, Oct 2 |
| Taylor BrentonEVP, Operations & R&D | Sell | 2,988 | $26.5K | Fri, Oct 2 |
| Badawi PaulPresident and CEO | Sell | 29,653 | $268.3K | Thu, Oct 1 |
| Badawi DavidChief Technology Officer | Sell | 7,797 | $70.6K | Thu, Oct 1 |
Sight Sciences (SGHT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The recent update lifts Sight Sciences’ fair value reference point from US$8.40 to US$9.40, giving investors a fresh anchor for thinking about upside and downside around the stock.
MENLO PARK, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences , Inc.
Dry eye adoption scaled while glaucoma gained major insurance coverage.
Sight Sciences Inc (SGHT) delivers its strongest quarterly growth in three years, driven by record dry eye revenue and improved operational efficiency.
Sight Sciences (NASDAQ:SGHT) reported second-quarter revenue growth of 20% year over year, supported by gains in its interventional glaucoma and interventional dry eye businesses, while reducing operating expenses and cash usage.
The fair value estimate for Sight Sciences has shifted from US$9.35 to US$8.40, pointing to a more measured central valuation in the latest update.
Sight Sciences (SGHT) delivered earnings and revenue surprises of +46.67% and +7.55%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
The headline numbers for Sight Sciences (SGHT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Raises Full-Year 2026 Revenue Guidance and Reduces Adjusted Operating Expense GuidanceMENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc.